The effectiveness of acne treatment: An assessment by patients of the outcome of therapy

British Journal of Dermatology

Volumn 137, Issue 4, 1997, Pages 563-567

  Newton, J N ^a   Mallon, E ^b   Klassen, A ^c   Ryan, T J ^b   Finlay, A Y ^d  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b CHURCHILL HOSPITAL   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ISOTRETINOIN;

ACNE; ADOLESCENT; ADULT; ARTICLE; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; TREATMENT OUTCOME; UNITED KINGDOM;

ACNE VULGARIS; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; ISOTRETINOIN; KERATOLYTIC AGENTS; MALE; PATIENT SATISFACTION; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 0030778708     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1997.tb03787.x     Document Type: Article

References (17)

1. Slevin ML, Plant H, Lynch D et al Who should measure quality of life, the doctor or the patient? Br J Cancer 1988; 57: 109-12.
2. Fitzpatrick R. Patient-centred approaches to the evaluation of health care. In: Essential Practice in Patient-centred Care. (Fulford W. Ersser S, Hope T, eds). Oxford: Blackwell Science, 1996: 229-40.
3. Streiner DL, Norman GR. Health Measurement Scales: A Practical Guide to their Development and Use. Oxford: Oxford University Press, 1989.
4. James M. Isotretinoin for severe acne. Lancet 1996; 347: 1749-50.
5. Cunliffe WJ, Gray JA, Macdonald-Hull S et al Cost effectiveness of isotretinoin. J Dermatol Treat 1991; 1: 285-8.
6. Simpson N. Effect of isotretinoin on the quality of life of patients with acne. Pharmacoeconomics 1994; 6: 108-13.
7. Burke BA, Cunliffe WJ. The assessment of acne vulgaris - the Leeds technique. Br J Dermatol 1984; 111: 83-92.
8. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-16.
9. Jenkinson C, Coulter A, Wright L. Short form 36 (SF36) health survey questionnaire: normative data for adults of working age. Br Med J 1993; 306: 1457-40.
10. Rosenberg M. Society and the Adolescent Self Image. Princeton: Princeton University Press, 1965.
11. Goldberg D, Williams P. A User's Guide to the General Health Questionnaire. Windsor: NFER-Nelson, 1988.
12. Kazis L, Anderson J, Meenan R. Effect sizes for interpreting changes in health status. Med Care 1989: 27: S178-89.
13. van der Meeren HL, van der Schaar WW, van den Hurk CM. The psychological impact of severe acne. Cutis 1985; 36: 84-6.
14. Rubinow DR, Peck GL, Squillace KM, Gantt GG. Reduced anxiety and depression in cystic acne patients after successful treatment with oral isotretinoin. J Am Acad Dermatol 1987; 17: 25-32.
15. Motley RJ, Finlay AY. Practical use of a disability index in the routine management of acne. Clin Exp Dermatol 1992; 17: 1-3.
16. Guyatt GH, Veldhuyzen Van Zanten SJ, Feeny DH, Patrick DL. Measuring quality of life in clinical trials: a taxonomy and review. Can Med Assoc J 1989; 140: 1441-8.
17. Chren MM, Lasek RJ, Quinn LM, Covinsky KE. Convergent and discriminant validity of a generic and a disease-specific instrument to measure quality of life in patients with skin disease. J Invest Dermatol 1997; 108: 103-7.